medigraphic.com

2019, Number 5

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2019; 57 (5)

Creatinin as predictor value of mortality in patients with acute coronary syndrome

Gómez-García A, Cruz-Balandrán J, Villatoro-Martínez A, Alvarez-Aguilar C

Language: Spanish
References: 25
Page: 277-283
PDF size: 183.85 Kb.


ABSTRACT

Background: Cardiovascular diseases have become the leading cause of death worldwide.
Objective: To estimate serum creatinine (Cr) as a prognostic value of mortality in patients with Acute Coronary Syndrome (ACS), which was admitted to the shock room in the emergency department (ED).
Material and Methods: A transversal, prospective study, which included 95 patients with ACS who were admitted to the shock room. The following variables were studied: laboratory tests with Cr, cardiovascular risk factors (CVRF), days of hospital stay, service to which it was derived and discharge condition (alive or dead). Statistical analysis was through SPSS v. 23.
Results: The diagnosis of admission was ACS without ST elevation (NSTE-ACS), 72.6%; and Acute Myocardial Infarction with ST elevation (STEMI), 27.4%. The 63.2% were discharged alive, 13.7% transferred to a third level hospital and 23.2% died. There was a difference in the level of Cr between living and deceased (p= 0.0001).
Conclusions: CR on admission of the patient with SCA provides prognostic information for mortality, and can be established as a prognostic marker of easy access and available in the ED.


REFERENCES

  1. Rosas-Peralta M, Arizmendi-Uribe E, Borrayo-Sánchez G. ¿De que fallecen los adultos en México? Impacto en el desarrollo económico y social de la nación. Rev Med Inst Mex Seguro Soc. 2017;55(1):99-103.

  2. Al SJ, Reddan DN, Williams K, Pieper KS, Harrington RA, Califf RM, et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation. 2002;106:974-980.

  3. Mostaza JM, Manzano L, Suárez C, Cairols MA, Ferreira EM, Rovira E, et al. Prevalencia de enfermedad arterial periférica asintomática, estimada mediante el índice tobillo-brazo, en pacientes con enfermedad vascular. Estudio MERITO II. Med Clin. 2008;131(15):561-565.

  4. Walsh CR, O´Donell CJ, Camargo CA Jr, Giugliano RP, Lloyd-Jones DM. Elevated serum creatinine is associated with 1-year mortality after acute myocardial infarction. Am Heart J. 2002;144(6):1003-1011.

  5. Dumaine R, Collet JP, Tanguy ML, Mansencal N, Dubois- Randé JL, Henry P, et al. Prognostic significance of renal insufficiency in patients presenting with acute coronary syndrome (the Prospective Multicenter SYCOMORE Study). Am J Cardiol. 2004;94(12):1543-7.

  6. Zakeri R, Freemantle N, Barnett V, Lipkin GW, Bonser RS, Graham TR, et al. Relation between mild renal dysfunction and outcomes after coronary artery bypass grafting. Circulation. 2005;112(9 Suppl):I270-5.

  7. Gibson CM, Pinto DS, Murphy SA, Morrow DA, Hobbach HP, Wiviott SD, et al. Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. J Am Coll Cardiol. 2003;42(9):1535-43.

  8. Freeman RV, Mehta RH, Al Badr W, Cooper JV, Kline- Rogers E, Eagle KA. Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors. J Am Coll Cardiol. 2003;41(5):718-24.

  9. PA, Soman SS, Shah SS, Smith ST, Marks KR, Yee J, et al. Risks associated with renal dysfunction in patients in the coronary care unit. J Am Coll Cardiol. 2000;36(3):679-84.

  10. National Kidney Foudation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39 (2 Suppl 1):S1-266.

  11. Treviño Becerra A, Baca Enciso R, Meza Coria C, Chávez Zúñiga MI, Gamboa Morales VE. Medición de la filtración glomerular comparativa por cistatina C y métodos convencionales basados en depuración de creatinina. Rev Hosp Jua Mex. 2010;77(1):22-27.

  12. Stevens LA, Coresh J, Greene Tom, Levey AS. Assessing kidney function- measured and estimated glomerular filtration rate. N Engl J Med. 2006;354(23):2473-83.

  13. Talavera JO, Rivas-Ruiz R, Bernal-Rosales LP. Tamaño de muestra. Rev Med Inst Mex Seguro Soc. 2011;49(5): 517-522.

  14. Sánchez-Arias AG, Bobadilla-Serrano ME, Dimas- Altamirano B, Gómez-Ortega M, González-González G. Enfermedad cardiovascular: primera causa de morbilidad en un hospital de tercer nivel. Rev Mex Cardiol. 2016;27 (s3):s98-s102.

  15. García-Castillo A, Jerjes-Sánchez C, Martínez-Bermúdez P, Azpiri-López JR, Autry-Caballero A, Martínez-Sanchez C, et al. RENASICA II, Registro Mexicano de Síndromes Coronarios Agudos. Arch Cardiol Mex. 2005;75(S1):S6-S19.

  16. Castillo-López B, Campusano-Valdés A, Hernández- Pedroso W, Trueba-Rodríguez D, López-Palomares M, Morejon-Carbonell D. Trombólisis: aplicación, posibilidad e inconvenientes. Rev Cub Med Int Emerg. 2007;6(3): 768-778.

  17. Armstrong PW, Cullen D, Antman E. Fibrinolysis for acute myocardial infarction: the future is here and now. Circulation. 2003;107(20):2533-7.

  18. Aronow WS. Thrombolysis and antithrombotic therapiy for coronary artery disease. Clin Geriatr Med. 2001;17 (1):173-88.

  19. Méndez-Durán A, Méndez-Bueno JF, Tapia- Yáñez T, Muñoz Montes A, Aguilar-Sánchez L. Epidemiología de la insuficiencia renal en México. Dial Traspl. 2010;31(1):7-11.

  20. Amato D, Álvarez-Aguilar C, Castañeda-Limones R, Rodríguez E, Ávila-Díaz M, Arreola F, et al. Prevalence of chronic kidney disease in an urban Mexican population. Kidney International. 2005;68(97):S1-S7.

  21. Instituto Nacional de Salud Pública. Encuesta Nacional de Salud y Nutrición de Medio Camino 2016: Resultados ponderados. Ciudad de México, México: INSP; 2016. Disponible en: https://www.gob.mx/cms/uploads/attachment/ file/209093/ENSANUT.pdf

  22. Carda-Barrio R, de Agustín JA, Manzano MC, García- Rubira JC, Fernández-Ortíz A, Vilacosta I, et al. Valor pronóstico intrahospitalario del filtrado glomerular en pacientes con síndrome coronario agudo y creatinina normal. Rev Esp Cardiol. 2007;60(7):714-9.

  23. Cabrerizo-García JL, Zalba-Etayo B, Pérez-Calvo JI. Valor pronóstico del filtrado glomerular en el síndrome coronario agudo: ¿índice de Cockcroft o ecuación MDRD? Med Clin. 2010;134(14):624-629.

  24. Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McClellan MB. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med. 2002;137(7):555-562.

  25. Margolis G, Vig S, Flint N, Khoury S, Barkagan M, Keren G, et al. Prognostic implications of Chronic Kidney disease on patients presenting ST-segment elevation myocardial infarction with versus without stent thrombosis. Cardiorenal Med. 2017;7(2):150-157.




2020     |     www.medigraphic.com